The Latest Cardiac and Vascular News
PARIS, July 05, 2021 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), biopharmaceutical company specializing in the development of a new class of drugs acting directly on the brain to treat resistant high blood pressure and heart failure, will present results of a preclinical study of QGC606 in heart failure […]
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures Reduced need for general anesthesia accelerates workflows, increases efficiency, and broadens treatment options Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in […]
The RESTORE trial will test the safety and efficacy of the HARPOON™ Beating Heart Mitral Valve Repair System. New minimally invasive device could reduce pain, complications and recovery time for mitral valve repair surgery. Hoag is one of only 40 sites in the world selected for this trial. NEWPORT BEACH, […]
REGULATED INFORMATION – INSIDE INFORMATION 1 July 2021, 07:00 am CEST Interim data from 26 patients in the Roll-In Cohort reconfirm positive outcomes against all primary endpointsi Over 90% reduction in mean frequency of therapeutic paracentesis versus baseline All patients experienced at least 50% reduction in mean frequency of therapeutic paracentesis per month versus baseline Clinically important improvement in quality of life maintained even up to 12 months post-implantation Safety profile remains in line […]
Merck and NGM will continue their research, discovery and development collaboration with a narrower scope, focused primarily on retinal and cardiovascular and metabolic (CVM) targets of interest to Merck Merck will continue to advance MK-3655, an FGFR1c/KLB agonistic antibody, currently in an ongoing global Phase 2b clinical trial in patients […]
Atlas, Carta’s AI-assisted data abstraction software, seamlessly automates submission to the ACC’s CathPCI clinical data registry, allowing healthcare organizations to maximize the benefits of registry contributions SAN FRANCISCO–(BUSINESS WIRE)–Carta Healthcare, a provider of artificial intelligence (AI)-powered clinical data abstraction technology and services, today announced that it is now a certified […]
American Heart Association consortium advances development of evidence-based health tech solutions PORTLAND, Maine–(BUSINESS WIRE)–Ginkgo Heart, LLC, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions. The […]
– New labeling approval for Abbott’s XIENCE™ stent builds on a legacy of safety and allows for one-month (as short as 28 days) dual anti-platelet therapy (DAPT) for patients at high bleeding risk (HBR) – The new XIENCE Skypoint™ stent received FDA approval in the U.S. and CE Mark approval […]
Further Analyses of GALACTIC-HF Supplement Previously Announced Data Regarding Increased Treatment Effect of Omecamtiv Mecarbil in Patients with More Severe Heart Failure SOUTH SAN FRANCISCO, Calif., June 30, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional results from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure) were presented at […]
PASADENA, Calif.–(BUSINESS WIRE)–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has dosed the first patient in AROANG3-2001, a Phase 2b clinical study of ARO-ANG3, the company’s investigational RNA interference (RNAi) therapeutic being developed as a treatment for patients with mixed dyslipidemia. Javier San Martin, M.D., chief medical officer at […]
